Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SAGE THERAPEUTIC RG (NQ: SAGE)
168.53 USD  +4.27 (+2.60%)
Streaming Delayed Price  /  Updated: 10:58 AM EDT, May 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 55,160
Open 166.00
Bid (Size) 168.36 (100)
Ask (Size) 168.74 (100)
Prev. Close 164.26
Today's Range 164.80 - 168.70
52wk Range 59.57 - 195.97
Shares Outstanding 46,515,858
Dividend Yield N/A
Performance
YTD
+1.12%
+1.12%
1 Month
+13.86%
+13.86%
3 Month
+3.28%
+3.28%
6 Month
+100.89%
+100.89%
1 Year
+151.95%
+151.95%
Top News
More News
Sage Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that members of... Read More
from Business Wire News Releases
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on May 1,... Read More
from Business Wire News Releases
More News
Read More
Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness
from Business Wire News Releases
Sage Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 3, 2018
from Business Wire News Releases
Investors Pick Up SAGE Even Lower Than Its Secondary Stock Offering
category Stocks
from Market News Video
IWO, SAGE, AZPN, NTNX: ETF Inflow Alert
category ETFs
from ETF Channel
Sage Therapeutics Submits New Drug Application to U.S. FDA for Intravenous Brexanolone in the Treatment of Postpartum Depression
from Business Wire News Releases
IWO, AZPN, SAGE, EXAS: ETF Outflow Alert
category ETFs
from ETF Channel
Sage Therapeutics Larger Than S&P 500 Component Harley-Davidson
category Stocks
from Market News Video
Analysts Forecast 24% Upside For The Holdings of FTXH
category ETFs
from ETF Channel
Sage Therapeutics to Present Brexanolone Postpartum Depression Data and SAGE-217 Major Depressive Disorder Data at Upcoming Spring Medical Meetings
from Business Wire News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial